论文导读：人工智能引导的信号对儿童多系统炎症综合征和川崎病共同宿主免疫应答反应的研究

刘嘉怡; 杨照玉; 王杰民; 焦富勇

doi:10.7499/j.issn.1008-8830.2208167

PDF(335 KB)

HTML

中国当代儿科杂志 ›› 2022, Vol. 24 ›› Issue (12) : 1318-1320. DOI: 10.7499/j.issn.1008-8830.2208167

川崎病专栏

论文导读：人工智能引导的信号对儿童多系统炎症综合征和川崎病共同宿主免疫应答反应的研究

刘嘉怡¹, 杨照玉¹, 王杰民², 焦富勇²

作者信息 +

文章历史 +

引用本文

EndNote

Ris (Procite)

Bibtex

导出引用

刘嘉怡, 杨照玉, 王杰民, 焦富勇. 论文导读：人工智能引导的信号对儿童多系统炎症综合征和川崎病共同宿主免疫应答反应的研究[J]. 中国当代儿科杂志. 2022, 24(12): 1318-1320 https://doi.org/10.7499/j.issn.1008-8830.2208167

参考文献

1 Ghosh P, Katkar GD, Shimizu C, et al. An artificial intelligence-guided signature reveals the shared host immune response in MIS-C and Kawasaki disease[J]. Nat Commun, 2022, 13(1): 2687. PMID: 35577777. PMCID: PMC9110726. DOI: 10.1038/s41467-022-30357-w.
2 Rodó X, Curcoll R, Robinson M, et al. Tropospheric winds from northeastern China carry the etiologic agent of Kawasaki disease from its source to Japan[J]. Proc Natl Acad Sci U S A, 2014, 111(22): 7952-7957. PMID: 24843117. PMCID: PMC4050536. DOI: 10.1073/pnas.1400380111.
3 Sahoo D, Katkar GD, Khandelwal S, et al. AI-guided discovery of the invariant host response to viral pandemics[J]. EBioMedicine, 2021, 68: 103390. PMID: 34127431. PMCID: PMC8193764. DOI: 10.1016/j.ebiom.2021.103390.
4 de Cevins C, Luka M, Smith N, et al. A monocyte/dendritic cell molecular signature of SARS-CoV-2-related multisystem inflammatory syndrome in children with severe myocarditis[J]. Med (N Y), 2021, 2(9): 1072-1092.e7. PMID: 34414385. PMCID: PMC8363470. DOI: 10.1016/j.medj.2021.08.002.
5 Ramaswamy A, Brodsky NN, Sumida TS, et al. Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children[J]. Immunity, 2021, 54(5): 1083-1095.e7. PMID: 33891889. PMCID: PMC8043654. DOI: 10.1016/j.immuni.2021.04.003.
6 Seyoum M, Enawgaw B, Melku M. Human blood platelets and viruses: defense mechanism and role in the removal of viral pathogens[J]. Thromb J, 2018, 16: 16. PMID: 30026673. PMCID: PMC6048695. DOI: 10.1186/s12959-018-0170-8.
7 Liao D, Zhou F, Luo L, et al. Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study[J]. Lancet Haematol, 2020, 7(9): e671-e678. PMID: 32659214. PMCID: PMC7351397. DOI: 10.1016/S2352-3026(20)30217-9.
8 Matsubara D, Kauffman HL, Wang Y, et al. Echocardiographic findings in pediatric multisystem inflammatory syndrome associated with COVID-19 in the United States[J]. J Am Coll Cardiol, 2020, 76(17): 1947-1961. PMID: 32890666. PMCID: PMC7467656. DOI: 10.1016/j.jacc.2020.08.056.
9 Tanni F, Akker E, Zaman MM, et al. Eosinopenia and COVID-19[J]. J Am Osteopath Assoc, 2020, 120(8): 504-508. PMID: 32672799. DOI: 10.7556/jaoa.2020.091.
10 Lindsley AW, Schwartz JT, Rothenberg ME. Eosinophil responses during COVID-19 infections and coronavirus vaccination[J]. J Allergy Clin Immunol, 2020, 146(1): 1-7. PMID: 32344056. PMCID: PMC7194727. DOI: 10.1016/j.jaci.2020.04.021.
11 Jesenak M, Brndiarova M, Urbancikova I, et al. Immune parameters and COVID-19 infection—associations with clinical severity and disease prognosis[J]. Front Cell Infect Microbiol, 2020, 10: 364. PMID: 32695683. PMCID: PMC7338601. DOI: 10.3389/fcimb.2020.00364.
12 Jesenak M, Schwarze J. Lung eosinophils—a novel "virus sink" that is defective in asthma?[J]. Allergy, 2019, 74(10): 1832-1834. PMID: 30972799. DOI: 10.1111/all.13811.
13 Huang PY, Huang YH, Guo MMH, et al. Kawasaki disease and allergic diseases[J]. Front Pediatr, 2020, 8: 614386. PMID: 33490002. PMCID: PMC7817814. DOI: 10.3389/fped.2020.614386.
14 Tsai CM, Chu CH, Liu X, et al. A novel score system of blood tests for differentiating Kawasaki disease from febrile children[J]. PLoS One, 2021, 16(1): e0244721. PMID: 33481812. PMCID: PMC7822339. DOI: 10.1371/journal.pone.0244721.
15 Liu XP, Huang YS, Xia HB, et al. A nomogram model identifies eosinophilic frequencies to powerfully discriminate Kawasaki disease from febrile infections[J]. Front Pediatr, 2020, 8: 559389. PMID: 33363059. PMCID: PMC7759494. DOI: 10.3389/fped.2020.559389.